Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in the fields of assay development, lab automation, Ultra-High-Throughput Screening (uHTS) and hit-to-lead biological profiling, in order to find novel leads for drug development.
We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community. Through this we help you accelerate drug discovery for a healthier society.
PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences.
✔ Integrated approach for early drug discovery
✔ Handling of large customer compound libraries
✔ Big pharma-like uHTS set-up and top-notch read-out technologies
✔ Very experienced screening site for ELF & pharma-accounts
✔ Broad knowledge in different assay development-solutions
✔ From disease targets to high-quality starting points for drug development
Interested? Get in touch and we’ll help you accelerate your drug discovery.
Developing the perfect high throughput biophysical assay using MS
Sometime ago I was inspired by a publication from Simon et al. (SLAS Discovery, 2020)* about possibilities to develop a
Pivot Park Screening Centre (PPSC) celebrates its 10-year anniversary
Oss, the Netherlands – 15 November 2022 Today Pivot Park Screening Centre celebrates its 10-year anniversary. PPSC builds on the
We started a program to identify novel hits that inhibit the interaction between the viral spike protein subunit S1 and human angiotensin-converting enzyme 2 (hACE2).
Cancer Drug Discovery Seminar – Opportunities and Challenges
During this in-person event, we are bringing together academic researchers from the Oncode Institute and industrial experts in the field of (immune-)oncology. Several experts in cancer drug discovery will present about topics such as: best practices for (early) target identification and validation, hit finding, and further downstream hit-to-lead activities.
Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…
Subscribe to our newsletter
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
